Authors
Latest:
Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK InhibitorsThis article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.
Latest:
Wearable Wrist Monitoring Devices Can Improve Atrial Fibrillation OutcomesThe use of devices like Apple watches may offer a more affordable and less burdensome modality to diagnose atrial fibrillation.
Latest:
APhA 2025: Building Pharmacy's Future With Mentorship, Advocacy, and Professional DevelopmentExpert emphasized the importance of mentoring pharmacy students, supporting diverse career paths, and advocating for the profession.
Latest:
Clinical Overview: Comparison of Anti-Amyloid Monoclonal Antibodies for Alzheimer DiseaseAducanumab, lecanemab, and donanemab are novel monoclonal antibodies designed to slow disease progression and hopefully have a positive impact in the field of Alzheimer disease management.
Latest:
Legal Battles Intensify: Pharmaceutical Manufacturers' Lawsuits Targeting Compounding PharmaciesAnalyzing the patent and trademark challenges faced by 503A compounding pharmacies.
Latest:
ADHD Medication Shortage and the National Fallout: What to do Now?Pharmacists are crucial in supporting patients with attention-deficit hyperactivity disorder as shortages of Adderall continue.
Latest:
Advancing Pharmacists’ Role in Personalized Treatment for Breast, Prostate, and Lung CancerPrecision oncology represents an evolution in therapeutic practice.
Latest:
Tips to Finding Balance: Being a Well-Rounded Student PharmacistFrom countless hours of studying to participating in pharmacy organizations to volunteering in the community, it’s no surprise that student pharmacists often struggle to find balance as a well-rounded student.
Latest:
Zuranolone Offers An Innovative Treatment for Postpartum DepressionZuranolone enhances health care providers’ ability to address the complex needs of patients with PPD, offering new hope for rapid and sustained relief from depressive symptoms.
Latest:
Three Health Care Drug Diversion Trends Are Shaping 2023Prevention, role of advanced machine learning systems, safety should be top of mind for next 12 months and beyond
Latest:
Three Methods for Effectively Training the Next Generation of Pharmacy LeadersTo develop the next generation of pharmacy leaders, pharmacists should receive effective training from the beginning of their careers.
Latest:
Mitigating the Effects of Ongoing Drug ShortagesThe ability—or lack thereof—to procure drugs can drive prices up and decrease patient accessibility.
Latest:
Introducing Tarlatamab-dlle: A New Era in Oncology TreatmentThe therapy offers new hope in solid tumor treatment with fewer adverse effects.
Latest:
Introducing Tarlatamab-dlle: A New Era in Oncology TreatmentThe therapy offers new hope in solid tumor treatment with fewer adverse effects.
Latest:
Embracing Digital Transformation: How Pharmacies Can Thrive in an Evolving Health Care LandscapePharmacies can adapt by embracing digital self-service options to better engage with patients, meet increasing consumer demand, and enhance revenue streams.
Latest:
Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK InhibitorsThis article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.
Latest:
Medication Therapy Management: How Pharmacists Are Personalizing Patient CarePharmacists have developed an expanded role in the team-based approach through medication therapy management.
Latest:
Clinical Overview: Certain Antihypertensive Drugs Can Lower Risk for New Onset Type 2 DiabetesMeta-analysis of randomized controlled trials adds to growing evidence around certain antihypertensive drug classes showing promise for primary or secondary prevention of diabetes.
Latest:
Revolutionizing Outpatient Oncology Care: The Seamless Integration of Artificial IntelligenceArtificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.
Latest:
So-Called “Ozempic Babies” Raise Questions About Unintended Effects of GLP-1 AgonistsAs of now, data suggest minimal risk of drug interactions between oral contraceptives and injectable semaglutide.
Latest:
Proof of Delivery is Key to Maximizing Pharmacy Reimbursement, Defending Audits and Preventing Costly Write-OffsFive crucial steps pharmacies can take to enhance patient engagement and lower operational costs.
Latest:
Concerns of the At-Home FluMist Emphasize Need for Patient Safety, Proper AdministrationIssues around patient safety, proper administration, and monitoring need careful consideration from pharmacists and other health care providers for vaccination efforts.
Latest:
Claims, Lab, and EHR Data Can Make or Break a Drug LaunchReal-world data can help resolve access barriers by providing a highly detailed view into the barriers that impact specific patient populations.
Latest:
Considerations for Environmentally Conscious Pharmacy StudentsEnvironmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.
Latest:
Integrating Biosimilars Into Retina and Neurology Practices Requires Careful PlanningSuccessfully integrating biosimilars into practices requires careful planning and execution, as they impact virtually all aspects of a practice.
Latest:
Improving Medication Reconciliation Accuracy in a Primary Care PracticeAccurate medication reconciliations are critical for ensuring safe patient outcomes, and a correct medication list can help prevent drug-drug interactions, contraindications, and duplicate therapies.
Latest:
Ashwagandha: A Case Example of the Supplement IndustryPerhaps ashwagandha may aid in stress management, athletic performance, and sleep, but this effect is far from definitive.
Latest:
Study: Developing MIS-C Remains Rare but Significantly More Likely for Unvaccinated ChildrenStudy shows that 98% of cases of multi-system inflammatory syndrome in children (MIS-C) were unvaccinated, suggesting that vaccination reduces the chance of a child who had COVID-19 later developing MIS-C.
Latest:
Managing Drug Interactions in HIV and TB Coinfection Is ComplexBest practices call for referring to resources, such as those from HHS and the University of Liverpool.
Latest:
Understanding the FDA Approval Process and PDUFA DatesThe FDA reviews NDAs and BLAs to approve medications for sale and marketing in the US with decisions required by the PDUFA date.
